ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NYMXF Nymox Pharmaceutical Corp (PK)

0.161
-0.009 (-5.29%)
16 Jul 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.76M283k224k299k116k5k00
Operating Income -17.66M-12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.65M
Pre Tax Income -17.88M-13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M
Net Income -17.88M-13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.416-0.267-0.238-0.164-0.185-0.151-0.147-0.073
EBIT -17.66M-12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.54M
EBITDA -17.66M-12.87M-13.23M-10.64M-13.33M-11.71M-12.49M-6.64M

Your Recent History

Delayed Upgrade Clock